Form DRS - Draft Registration Statement:
SEC Accession No. 0000912057-14-000419
Filing Date
2014-10-29
Accepted
2014-10-29 16:46:44
Documents
18

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1504842
2 filename2.htm EX-3.1 195047
3 filename3.htm EX-3.2 10976
4 filename4.htm EX-3.3 10865
5 filename5.htm EX-3.4 11305
6 filename6.htm EX-3.6 237337
7 filename7.htm EX-4.2 236996
8 filename8.htm EX-10.9 64575
9 g125534.jpg GRAPHIC 28226
10 g218148.jpg GRAPHIC 20985
11 g376796.jpg GRAPHIC 10019
12 g453622.jpg GRAPHIC 16588
13 g503007.jpg GRAPHIC 18750
14 g684024.jpg GRAPHIC 26627
15 g812709.jpg GRAPHIC 26009
16 g822044.jpg GRAPHIC 26185
17 g833773.jpg GRAPHIC 34694
18 g926785.jpg GRAPHIC 30485
  Complete submission text file 0000912057-14-000419.txt   2602825
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-00826 | Film No.: 141180673
SIC: 2834 Pharmaceutical Preparations